Novacea, Schering-Plough Ink Deal To Develop, Commercialize Cancer Drug Asentar
This article was originally published in The Pink Sheet Daily
Executive Summary
Novacea emphasizes collaborative nature of the agreement, pointing to pre-commercial milestones and larger-than-usual royalties on sales.